| Name | Market | Market CAP | Share price | Daily share movement |
|---|---|---|---|---|
| 712 North | PRIVATE | 0.00 | 0% | |
| 7D Surgical | PRIVATE | 0.00 | 0% | |
| 7Digital Group PLC | AIM | £4.17 m | 0.17 GBX | 0% |
| 808 Renewable Energy Corp. | OTCMKTS | $710.38 k | 0.01 USD | -48.60% |
| 88 Energy Ltd | AIM | £68.72 m | 1.00 GBX | 8.11% |
| 888 Holdings | NEX | 0.00 | 0% | |
| 8common | ASX | $15.64 m | 0.10 AUD | 2.04% |
| 8I Holdings Limited | ASX | $28.96 m | 0.08 AUD | 0% |
| 8x8 Inc | NYSE | $1.72 billion | 17.17 USD | 2.14% |
| 9 Spokes International Ltd | ASX | $16.13 m | 0.02 AUD | 6.25% |
| 99 Bitcoins | PRIVATE-NA | 0.00 | 0% | |
| 99 Wuxian Ltd | ASX | $76.54 m | 0.07 AUD | 0% |
| A&J Mucklow Group PLC | LSE | £0.00 | 0.00 GBX | 0% |
| A-Cap Resources Ltd | ASX | $7.85 m | 0.01 AUD | 0% |
| A-Mark Precious Metals Inc | NASDAQ | $63.42 m | 9.02 USD | -0.77% |
| A.I.S. Resources Limited | TSX-V | 0.00 | 0% | |
| A.O. Smith | NYSE | $7.59 billion | 46.52 USD | -0.58% |
| A.T. Cross | NASDAQ | 0.00 | 0% | |
| A1 Consolidated Gold | ASX | 0.00 | 0% | |
| A1 Investments & Resources | ASX | $24.02 m | 0.00 AUD | 0% |
| A10 Networks Inc | NYSE | $487.8 m | 6.35 USD | -1.24% |
| A123 Systems | NASDAQ | 0.00 | 0% | |
| A2 Milk Co Ltd. | OTCMKTS | $7.41 billion | 10.08 USD | -0.25% |
| AA PLC | LSE | £322.56 m | 52.35 GBX | 6.66% |
| AAC Holdings Inc | NYSE | 0.00 | 0% | |
| AAR | NYSE | $1.56 billion | 44.62 USD | -0.91% |
| AB Dynamics PLC | AIM | £505.16 m | 2,250.00 GBX | 3.69% |
| AB Science, Paris | OTCMKTS | $232.95 m | 5.60 USD | 2.38% |
| AB&T Financial Corp. (NC) | OTCMKTS | $1.29 m | 0.49 USD | -3.00% |
| Abacus Health Products, Inc. | CSE | $73.92 m | 5.85 CAD | 1.74% |
| Abacus Mining & Exploration Corp. | TSX-V | $2.85 m | 0.06 CAD | 0% |
| Abacus Property Group | ASX | $2.3 billion | 3.57 AUD | -1.65% |
| Abattis Bioceuticals | CSE | $0.00 | 0.00 CAD | 0% |
| Abbey plc | AIM | £253.15 m | 1,205.00 GBX | -1.23% |
| Abbey Protection | PRIVATE-UK | 0.00 | 0% | |
| Abbeycrest | LSE | 0.00 | 0% | |
| Abbott Laboratories | NYSE | $152.71 billion | 86.35 USD | 0.44% |
| Abbvie | NYSE | $129.9 billion | 87.84 USD | -1.00% |
| Abcam | AIM | £2.85 billion | 1,381.00 GBX | 0.29% |
| Abcam | AIM | £2.85 billion | 1,381.00 GBX | 0.29% |